Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “derivative”

1,342 pharma patents match "derivative" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,342
Index total 30,257
Page 15 / 56

Quick answer

This filtered view shows 1,342 pharmaceutical patents matching "derivative" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,342 results for “derivative” · 30,257 patents in full index Clear search

  1. US 10220078

    Methods of using thrombin derivatives to treat medulloblastoma

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  2. US 10220042

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  3. US 10220029

    Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  4. US 10214487

    Indole derivatives and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  5. US 10213456

    Alginate oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same

    OCEAN UNIVERSITY OF CHINA · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  6. US 10214509

    Amino-substituted heterocyclic derivatives as sodium channel inhibitors

    Almirall, S.A. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  7. US 10208081

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  8. US 10208016

    1-sulfonyl piperidine derivatives as modulators of prokineticin receptors

    Takeda Pharmaceutical Company Limited · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  9. US 10206904

    Licofelone derivatives and methods of use

    The Board of Regents of the University of Oklahoma · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  10. US 10196377

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  11. US 10189859

    Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

    Nektar Therapeutics · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  12. US 10183055

    Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  13. US 2019008774

    PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME

    BIAL PORTELA & Cª S A [PT] · Granted Jan 10, 2019 · Expires Jan 5, 2039

    granted

  14. US 10173985

    Aminoindazole derivatives as sodium channel inhibitors

    Almirall, S.A. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  15. US 10173989

    1,2,4-oxadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  16. US 10167273

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  17. US 10160745

    Piperidine and azepine derivatives as prokineticin receptor modulators

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  18. US 10160736

    1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  19. US 10155747

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  20. US 10155744

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  21. US 10155745

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  22. US 10155746

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  23. US 10155743

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  24. US 10144753

    Anthracycline derivatives for treating tumor diseases

    Produkem Molekulares Design GMBH · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.